TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/31/22 16:30 | 1/27/22 | ETNB | 89Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Palekar Rohan | CA | DO | CEO | P.m | 53 | 7.05 | 0 | 8 | 20 | 46 | D | ||||||||||||||
7/8/21 16:05 | 7/7/21 | ETNB | 89Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Palekar Rohan | CA | DO | CEO | P.m | 118 | 16.84 | 0 | 7 | 23 | 37 | D | ||||||||||||||
12/19/13 16:31 | 12/17/13 | AVNR | Avanir Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Palekar Rohan | CA | O | SVP,Chie | P | 28 | 2.80 | 0 | 10 | 8 | 143 | D | ||||||||||||||
11/5/13 20:01 | 11/4/13 | AVNR | Avanir Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Palekar Rohan | CA | O | SVP,Chie | P | 42 | 4.19 | 0 | 10 | 8 | 133 | D | ||||||||||||||
12/17/12 16:15 | 12/13/12 | AVNR | Avanir Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Palekar Rohan | CA | O | SVP,Chie | P | 25 | 2.46 | 0 | 10 | 20 | 60 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |